Personal Account
Personal Account
A running list of upcoming and recently priced US IPOs, updated weekly. Dates, price ranges and deal sizes change frequently ahead of pricing — treat the table below as a snapshot as of September 18, 2026, and confirm details before making any decision.
Upcoming and Recent IPOs
| Company | Ticker | Price Range | Est. Deal Size | Expected Date |
|---|---|---|---|---|
| Electra Therapeutics | ETRA | Priced at $15.00 | $350.0M | Priced 9/18/2026 |
| Orion180 Insurance Group | OIG | Priced at $12.00 (below $15.00–$17.00 range) | $240.0M | Priced 9/18/2026 |
| Leader's Advantage Acquisition Corp. | LEDRU | Priced at $10.00 | $150.0M | Priced 9/18/2026 |
| American Savings Bank of Hawaii | ASBH | Priced at $16.00, first-day close $17.00 | $120.0M | Priced 9/16/2026 |
| Bamboo Insurance Services | BMB | $18.00–$20.00 | $665.0M | 9/23/2026 |
| Amaero (Cross-Listing) | AMRO | $7.06 | $52.7M | 9/23/2026 |
| BW Industrial Holdings | BWGC | $6.00–$7.00 | $17.1M | Week of 9/24/2026 |
| Web3Labs Global | MDAT | $4.00–$5.00 | $28.1M | Week of 9/24/2026 |
| Encore Medical Inc. | EMI | $5.00 | $15.0M | 9/30/2026 |
What to Watch
The IPO market reopened this week after a quiet stretch, with four deals pricing between September 16 and September 18. The headline was Electra Therapeutics (ETRA), a late clinical-stage immunology and oncology biotech, which priced 23.3 million shares at $15.00 — the upper half of its $14–$16 range — to raise roughly $350 million, the largest operating-company deal of the week. Orion180 Insurance Group (OIG), a Melbourne, Florida-based excess-and-surplus homeowners insurer, priced below its marketed $15–$17 range at $12.00, raising $240 million, a sign that investor appetite for smaller insurance names is more selective than for biotech right now. Hawaii's American Savings Bank (ASBH) priced its NYSE listing at $16.00 on September 16 and closed its first day at $17.00, a modest but positive debut for the bank-holding offering. A blank-check vehicle, Leader's Advantage Acquisition Corp. (LEDRU), also priced a $150 million SPAC deal on September 18. Looking ahead, Bamboo Insurance Services (BMB) is on deck for September 23 with an $18–$20 range targeting up to $665 million, which would be the largest deal on the calendar over the next two weeks.
Off the calendar but still dominating headlines: with Anthropic's confidential S-1 still unpublished, pre-IPO speculation has moved into crypto derivatives markets. Perpetual futures tracking Anthropic's eventual public valuation traded on Hyperliquid this week at an implied market cap as high as $2.36 trillion — more than double the $965 billion price set in its May Series H round — even though no Anthropic shares yet exist to trade. Anthropic has also moved to void any unauthorized transfers of its stock ahead of a listing, including through tokenized products or special-purpose vehicles, a detail worth watching for anyone holding synthetic pre-IPO exposure.
Why It Matters for Pre-IPO and Tokenized Equity Investors
This week's mixed results — a strong reception for Electra Therapeutics against a discounted price for Orion180 — are a reminder that public IPO demand can be uneven even in an active week, and that signal feeds into the broader private-to-public pipeline that Pre-IPO and tokenized equity investors track. The Anthropic perpetual futures trading at an implied valuation above $2 trillion show there is real demand for exposure to pre-IPO AI leaders, but Anthropic's own move to void unauthorized token transfers is a pointed reminder that synthetic or tokenized exposure to a private company carries risks a public listing does not, until the underlying shares are actually registered and tradeable. Investors weighing tokenized pre-IPO exposure to Anthropic, OpenAI, or SpaceX should treat derivatives pricing as a sentiment gauge, not a guaranteed path to the eventual IPO price.
This material is for informational purposes only and does not constitute individual investment advice.